Skip to main content
Erschienen in: International Urology and Nephrology 4/2019

28.01.2019 | Nephrology - Original Paper

Increased risk of new-onset type 2 diabetes in people with chronic kidney disease

verfasst von: I-Kuan Wang, Tsung-Hsun Tsai, Yi-Chih Hung, Tzu-Yuan Wang, Tzung-Hai Yen, Cheng-Li Lin, Fung-Chang Sung

Erschienen in: International Urology and Nephrology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study investigated whether people with chronic kidney disease (CKD) are at the risk of new-onset type 2 diabetes.

Methods

A cohort comprising 16,624 people with CKD, and an age- and sex-matched control cohort of 66,496 persons without any clinical kidney disease were identified from the Taiwan National Health Insurance Database during the period of 2000–2010. Both cohorts were followed up to 2011 to evaluate the incidence and hazard ratio (HR) of developing new-onset type 2 diabetes. Diseases were identified based on diagnosis coding.

Results

The incidence of type 2 diabetes was 1.51-fold higher in the CKD cohort than in the control cohort (16.9 versus 11.2 per 1,000 person-years) with an adjusted hazard ratio of 1.17 (95% confidence interval, (CI)1.10–1.24). In the multivariate Cox regression model considering the competing-risk death, the adjusted subhazard ratio of type 2 diabetes was 1.30 (95% CI1.22–1.38) for the CKD cohort compared to the control cohort.

Conclusions

People with CKD patients are at an increased risk of developing new-onset type 2 diabetes. Close surveillance for diabetes should be considered for these people.
Literatur
1.
Zurück zum Zitat Renal Data System US, USRDS 2014 Annual Data Report: Atlas of Chronic Kidney and End-Stage Renal Disease in the United States, National Institue of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD Renal Data System US, USRDS 2014 Annual Data Report: Atlas of Chronic Kidney and End-Stage Renal Disease in the United States, National Institue of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
4.
6.
Zurück zum Zitat Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T (2005) Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 45(2):275–280CrossRefPubMed Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T (2005) Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 45(2):275–280CrossRefPubMed
12.
Zurück zum Zitat Hu FB, Meigs JB, Li TY, Rifai N, Manson JE (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53(3):693–700CrossRefPubMed Hu FB, Meigs JB, Li TY, Rifai N, Manson JE (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53(3):693–700CrossRefPubMed
13.
Zurück zum Zitat Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286(3):327–334CrossRef Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286(3):327–334CrossRef
14.
Zurück zum Zitat Lu JF, Hsiao WC (2003) Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff (Millwood) 22(3):77–88CrossRef Lu JF, Hsiao WC (2003) Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff (Millwood) 22(3):77–88CrossRef
18.
Zurück zum Zitat Friedman JE, Dohm GL, Elton CW, Rovira A, Chen JJ, Leggett-Frazier N, Atkinson SM Jr, Thomas FT, Long SD, Caro JF (1991) Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors. Am J Physiol 261(1 Pt 1):E87–E94PubMed Friedman JE, Dohm GL, Elton CW, Rovira A, Chen JJ, Leggett-Frazier N, Atkinson SM Jr, Thomas FT, Long SD, Caro JF (1991) Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors. Am J Physiol 261(1 Pt 1):E87–E94PubMed
20.
Zurück zum Zitat Vaziri ND, Liang K (1996) Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Kidney Int 50(6):1928–1935CrossRefPubMed Vaziri ND, Liang K (1996) Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Kidney Int 50(6):1928–1935CrossRefPubMed
21.
Zurück zum Zitat Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J (2003) Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14(2):469–477CrossRefPubMed Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J (2003) Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14(2):469–477CrossRefPubMed
25.
Zurück zum Zitat Hanson RL, Imperatore G, Bennett PH, Knowler WC (2002) Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes 51(10):3120–3127CrossRefPubMed Hanson RL, Imperatore G, Bennett PH, Knowler WC (2002) Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes 51(10):3120–3127CrossRefPubMed
27.
Zurück zum Zitat Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY (2005) Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc 104(3):157–163PubMed Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY (2005) Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc 104(3):157–163PubMed
Metadaten
Titel
Increased risk of new-onset type 2 diabetes in people with chronic kidney disease
verfasst von
I-Kuan Wang
Tsung-Hsun Tsai
Yi-Chih Hung
Tzu-Yuan Wang
Tzung-Hai Yen
Cheng-Li Lin
Fung-Chang Sung
Publikationsdatum
28.01.2019
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 4/2019
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-019-02075-8

Weitere Artikel der Ausgabe 4/2019

International Urology and Nephrology 4/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.